Priority Date: 11.01.08 (US 20080020573P)
Polypeptide vaccine and vaccination strategy against mycobacterium
- Application ID: EP14176196
- Status: █ EXAMINATION IN PROGRESS
Attorneys
operating since 1995
Headquarter in Copenhagen
and
1 office
active in Legal Services and IP Consulting
operating since 2003
Headquarter in Madrid
and
1 office
active in Legal Services and IP Consulting
Specialization
This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Høiberg A/S and ABG Patentes SL are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 220 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.
Timeline
- 11.01.2008 - Priority Date (US 20080020573P)
- 31.12.2014 - Publication A1 (EP2818178)